|
|||||||
|
|||||||
|
|
|
||||||
|
|
Cyproterone Acetate (Diane 35®)Drug ClassAnti-androgen; progestin Dosage FormsOral: Tablets: Cyproterone acetate 2mg w/ ethinyl estradiol 35mcg Diane-35®
Cyproterone acetate has been found useful in androgen-related dermatologic disorders, such as hirsutism and acne vulgaris. The anti-androgen activity is responsible for the decreased sebum excretion rate and the inhibition of hair growth. If used alone in women cyproterone leads to menstrual cycle disturbances which can be avoided when combined with ethinyl estradiol.
Patient MonitoringLiver function tests every 6 months are recommended. Drug Safety Information
Adverse EffectsCutaneous effects may include dry skin, thrombophlebitis, photosensitivity, alopecia, and maculopapular rash. FDA Pregnancy Category XContraindicated during pregnancy and lactation. Feminization will occur in the male fetus. Major Drug InteractionsConcurrent use of antihypertensive, benzodiazepines, beta-adrenergic blockers, corticosteroids, hypoglycemic and tricyclic antibiotics may alter their efficacy; anticoagulant effect may be reduced; ampicillin, analgesics, antihistamines, chloramphenicol, penicillin and tetracyclines may reduce contraceptive efficacy. Mechanism of Action / PharmacokineticsCyproterone acetate blocks androgen receptors and reduces androgen synthesis through negative feedback on the hypothalamo-pituitary-gonadal axis. The antiandrogen activity is thought to lead to decreased hair growth as well reduce sebum production. |
||||||
|
All content ©2005
Skin Care Guide.com Ltd. All Rights Reserved.
|
|||||||